Does HHC show up on a drug test, drug screening or DGT roadside test?

HHC, or hexahydrocannabinol, is a semi-synthetic cannabinoid derived from THC (tetrahydrocannabinol) that became popular across Europe from 2022 as a supposedly “legal” alternative to psychoactive cannabis, before Spain banned it in 2025, joining France, Germany, Italy and other European countries. The question every user asks sooner or later: does HHC show up on a drug test? What about a roadside test by the Spanish Traffic Authority (DGT)? And on a workplace drug screening?

Three key takeaways

• Yes, HHC can test positive on a drug test. Not because of HHC itself, but because of its main metabolite (11-OH-HHC) and because most HHC products in Europe also contain residual THC.
• In a DGT roadside check, the rapid saliva screening test can come back positive through cross-reactivity with THC; a confirmatory laboratory analysis would clear it up but, in the meantime, your vehicle is immobilised and you are reported.
• In a urine drug screening (workplace, sports, military), the risk increases because the detection window for cannabinoids in urine can extend up to 30 days in regular users.

Why HHC shows up on drug tests

HHC (hexahydrocannabinol) is a semi-synthetic cannabinoid produced by chemical hydrogenation of THC, or tetrahydrocannabinol — a process similar to the one that converts liquid vegetable oils into solid margarine. The result is a molecule very similar to tetrahydrocannabinol, with comparable psychoactive effects (a high, altered perception, motor incoordination, red eyes, dry mouth), although somewhat milder according to users.

If you are looking for the full guide to this cannabinoid, here we explain what HHC is.

HHC products appeared on the European market from 2022 and were sold by exploiting a legal loophole: since HHC was not expressly prohibited, it was sold as “legal” in grow shops, head shops and online shops. Since then, France (2023), Germany (2024), Italy, Austria, Belgium, Denmark, Spain (2025) and other countries have banned or restricted it expressly.

Typical HHC products include:

• Disposable vapes and HHC cartridges
• Hemp flower sprayed with HHC (visually identical to CBD flower)
• Hash with HHC or sprayed hash
• Gummies and edibles containing HHC
• New derivatives: HHC-P (more potent), HHC-O (acetate), 10-OH-HHC

Does HHC test positive on a drug test?

Yes, HHC can test positive on standard drug tests, especially urine tests and laboratory immunoassays. The answer depends on three factors: the type of test and the device used, which metabolites the lab is screening for, and whether the product consumed contained only pure HHC or also residual THC.

Standard drug tests are designed to detect 11-nor-9-carboxy-THC (THC-COOH), the main metabolite of tetrahydrocannabinol. HHC is metabolised in the liver into 11-hydroxy-HHC (11-OH-HHC) and 11-nor-carboxy-HHC (11-COOH-HHC), two molecules chemically very similar to the THC metabolites. The 47th WHO critical review on HHC (1) confirms that HHC metabolites show cross-reactivity with THC-COOH in immunoassays, so they can produce a “THC positive” result without any cannabis use.

In addition, according to the EMCDDA (now EUDA, 2023) technical report (3), products sold as “HHC” on the European market have been found to actually contain a mixture of HHC and THC coming from unpurified starting material. This multiplies the risk of a positive result even if the user believes they are only taking HHC.

Important: HHC pharmacokinetics in humans are still being studied. The windows given below are estimates based on clinical THC data, preliminary HHC pharmacokinetic studies (2) and the WHO review (1) — they can vary by device, dose and individual metabolism.

Urine drug screening (workplace, sports, military)

Urine testing is the most common in workplace drug screenings (transport companies, construction, healthcare), sports settings (federations, WADA) and the military. It detects metabolites over days or weeks:

• Occasional user: estimated window of 3 to 7 days
• Frequent user (several times per week): estimated window of 7 to 14 days
• Chronic daily user: may exceed 30 days due to accumulation of fat-soluble metabolites in adipose tissue

In a controlled study with 25 mg of oral HHC and three puffs from an HHC vape (2), a rapid urine test (SureStep™, cut-off 50 ng/mL of THC-COOH) came back positive in all participants and, after oral intake, up to 72 hours later, even after a single low dose.

Saliva test (the one used by the DGT)

This is the test the DGT uses in roadside checks, and it is also used in some drug-testing protocols on construction sites (more detail in saliva test for THC and what to do if you test positive). It returns a result in minutes, but the evidence on HHC is mixed:

• The Höfert et al. study (2) with the DrugWipe® 5S device (one of the most commonly used in DGT roadside checks, cut-off 5 ng/mL of THC) only returned a positive in the first 10 minutes after controlled low doses (probably because of HHC residue in the mouth) and was negative afterwards, except in one case at 3 hours
• A laboratory serum immunoassay (ELISA) did return a positive for at least 24 hours in almost all participants in the same study (2)
• High doses, repeated use or products containing residual THC can alter this result: if the product contains THC alongside HHC, a positive is very likely

In practice: even if the saliva drug-test device is not calibrated for HHC, traces of THC in the product are enough (something common in Europe according to the EMCDDA) (3) for the test to come back positive.

Blood test

Measures the active presence of the cannabinoid, not its metabolites. It is the test used as a counter-analysis, if the driver requests it, after a positive saliva test. HHC has a short plasma half-life (~1.3–1.6 h according to the WHO review) (1):

• After acute use: detectable for 2–12 hours
• Chronic user: THC and its metabolites can persist for up to several days (data extrapolated; no HHC studies with a sufficient sample size yet)

Hair test

The widest window. Detects use over the past 3 months (1 cm of hair ≈ 1 month of exposure). Used in forensic assessments, child custody cases and security-personnel recruitment. No specific protocols for HHC detection in hair have yet been published, but its metabolites share structure with those of THC and are assumed detectable by the same chromatographic methods.

HHC and DGT roadside checks: can I be fined?

In a routine DGT roadside check, the procedure is always the same: the Guardia Civil or local police first ask you to blow into an alcohol breathalyser, and if there is any suspicion they then apply a saliva test with a rapid device (Dräger DrugTest 5000, Securetec DrugWipe 5S or others) that screens for several substances: THC, cocaine, amphetamines, methamphetamines, opiates and benzodiazepines.

These devices are not calibrated to detect HHC directly. The Höfert et al. study (2) with the DrugWipe® 5S only returned a positive in the first few minutes after controlled low doses, suggesting that with pure HHC and moderate doses the rapid saliva test might not detect it. But there are three reasons why a positive result remains likely in practice:

• Almost all commercial HHC products in Europe contain residual THC according to the EMCDDA-EUDA report (3), and THC does trigger the device
• Repeated use or high doses: increase the likelihood of cross-reactivity through accumulated metabolite concentration
• Other devices different from the DrugWipe can have different cross-sensitivities (published evidence covers only a few devices)

The confirmatory laboratory analysis (gas or liquid chromatography coupled to mass spectrometry) can distinguish HHC from THC accurately, but that analysis takes weeks. In the meantime:

• Your vehicle is immobilised and you cannot carry on driving if you test positive on the screening test
• Penalty proceedings begin (a fine of €1,000 + the loss of 6 points, under article 27 of Spain’s General Traffic Regulations (5))
• Appealing the fine with the confirmatory analysis or counter-analysis can take 6–12 months

Practical conclusion: if you use HHC products, do not drive. The risk of a positive in a DGT check is real (whether from residual THC or from high doses) and the administrative consequences are the same as with cannabis: the loss of 6 points and a fine. And since 23 April 2025, HHC and its derivatives have been banned in Spain by Order SND/380/2025 (4), so their use and possession add legal liability on top of the administrative traffic penalty.

How long should I wait before driving after using HHC?

There is no official threshold because HHC was not covered by traffic legislation before 2025. As a safe reference, extrapolating from THC data and the preliminary HHC pharmacokinetic studies (2):

• Occasional use (1 vape, one gummy, one bud): a minimum of 24 hours
• Intense acute use (several doses in a row): 48–72 hours
• Regular use (several times per week): at least one week

These timeframes are indicative. If you have a scheduled check (driving licence renewal, occupational medical check-up, sports anti-doping), the prudent approach is to stop using 30 days beforehand and, if possible, request a confirmatory laboratory analysis to make sure the metabolite concentration is below the threshold.

11-OH-HHC: the metabolite that does show up (and why it matters)

11-OH-HHC (11-hydroxy-HHC) is the main metabolite of HHC in the human body. When you take HHC, the liver transforms it into 11-OH-HHC, a molecule that is pharmacologically more active than the original HHC — comparable to the relationship between THC and its metabolite 11-OH-THC.

And this is the problem: 11-OH-HHC is chemically almost identical to 11-hydroxy-THC, and its end product, 11-COOH-HHC, closely resembles THC-COOH, the molecule that urine tests are specifically designed to detect. So even if HHC were 100% pure (with no residual THC), there would still be a high risk of a positive through metabolite cross-reactivity.

Other HHC derivatives with similar risk:

• HHC-P (hexahydrocannabiphorol) — a more potent analogue, even less studied
• HHC-O (HHC acetate) — an ester with reportedly more intense and longer-lasting effects
• 9-OH-HHC — another hydroxylated HHC derivative

All of them share a molecular core with THC and all can generate metabolites detectable in urine. There is not yet enough clinical data on the exact detection windows for these compounds in humans, which adds uncertainty: any product containing HHC, HHC-P, HHC-O or their mixtures should be assumed potentially positive on a drug screening.

HHC, THC and CBD on a drug test: comparison

The three most talked-about cannabinoids behave very differently in a drug screening:

If you want to dig deeper into each case:

• Differences between HHC and THC
• Differences between CBD and HHC
• Differences between HHC and H4CBD
• Does CBD test positive on a drug test?

How long does HHC stay in the body?

The detection window depends on five factors:

• Frequency of use: occasional vs regular use can mean up to a fourfold difference
• Dose and concentration: a 1 g vape of 95% HHC ≠ flower sprayed with a variable concentration
• Route of administration: vaped or smoked HHC is eliminated faster than HHC eaten in gummies
• Individual metabolism: age, weight, body fat, hydration, liver function
• Product purity: if it contains residual THC, the window multiplies

Indicative summary (no definitive clinical data for HHC):

For reference, regular cannabis users can test positive in urine for more than 30 days after stopping use, whereas a single exposure in non-users can be detected for up to 72 hours. HHC behaves in a similar way.

HHC risks: adulteration, legal status and adverse effects

The most concerning thing about HHC is not only its potential positive on a drug screening, but the open questions about its safety:

• Lack of control and dosing: HHC is produced at industrial scale without pharmaceutical standards. Amounts, purity and by-products vary from batch to batch.
• Undeclared mixtures: according to the EMCDDA technical report (3), products labelled as “HHC” on the European market have actually been found to contain a mixture of HHC, THC, HHC-P or residual solvents.
• Reported adverse effects: mood alteration, anxiety and panic attacks (especially in first-time users), nausea, tachycardia, vomiting at high doses, psychological dependence with continued use.
• Banned across much of Europe: France (2023), Germany (2024), Spain (23 April 2025, Order SND/380/2025) (4), Italy, Austria, Belgium, Denmark, Switzerland and others banned or restricted it between 2023 and 2025. The Spanish decision aligns with the inclusion of HHC in Schedule II of the 1971 Convention on Psychotropic Substances by the UN Commission on Narcotic Drugs (March 2025).

Frequently asked questions about HHC and drug tests

Can I test positive from passive HHC smoking?

Very unlikely, but not impossible. Passive exposure to regular cannabis smoke only produces a positive result in extreme conditions (small, unventilated spaces, prolonged exposure to dense smoke) and with low laboratory cut-offs. The same rule applies to HHC: the metabolite concentration absorbed passively rarely exceeds the detection threshold of a standard urine test (25–50 ng/mL of THC-COOH). On a saliva or blood test, traces could appear for a few hours if the exposure was intense.

Will HHC show up in a routine medical test (not a drug screening)?

No. A routine company or private-insurance blood test (full blood count, biochemistry, lipid profile, liver function) does not look for cannabinoids. These analyses are only requested in specific contexts: an occupational medical check-up with a drug-testing clause, sports anti-doping, a forensic assessment, military enlistment or treatment in an addiction unit. Unless the doctor specifically orders a toxicology screening, HHC will not appear on the report.

Is HHC legal in Spain?

No. On 23 April 2025 Order SND/380/2025 (4) came into force, adding HHC and its derivatives (HHC-O, HHCP, THCP, THC-O, H4-CBD, among others) to Schedule II of psychotropic substances under Royal Decree 2829/1977. Their manufacture, sale, possession and recreational use are banned, with Spain joining France (2023), Germany (2024), Italy, Austria, Belgium, Denmark and other European countries. At Cannactiva we do not recommend buying HHC or other semi-synthetic cannabinoids: they are synthetic in origin, their traceability is doubtful, and serious cases have been seen. If anyone still wants to do so, they should check the law in their country very carefully, because it is dangerous.